Ryan G, Latimer K M, Dolovich J, Hargreave F E
Thorax. 1982 Jun;37(6):423-9. doi: 10.1136/thx.37.6.423.
Features of asthma include increases in both bronchial responsiveness and variability of airflow rates. We examined the relationship between bronchial responsiveness to histamine and the variation of peak expiratory flow rate (PFR) during the day and in response to salbutamol (200 μg), and the initial FEV at the time of the histamine test and FEV response to salbutamol. Bronchial responsiveness to histamine was expressed as the provocation concentration causing a fall in FEV of 20% (PC). PC ranged between 13·9 and 130 mg/ml in nonasthmatic subjects, between 10·5 and 59·9 mg/ml in five asymptomatic asthmatics, and between 0·03 and 20·8 mg/ml in 27 asthmatics with symptoms controlled by medication. The lower the PC (the greater the bronchial responsiveness) the lower the morning PFR (r = 0·79), the greater the increase in PFR after salbutamol (morning r = −0·75, evening r = −0·80), and the greater the difference between the highest and lowest PFR each day (r = −0·81). Measurements of PFR were abnormal, compared with those in nonasthmatic subjects, in all subjects with a PC less than 2 mg/ml—that is, moderate or severe increase in nonspecific bronchial responsiveness—and in none with a PC greater than 21 mg/ml—that is, normal responsiveness; five of nine asthmatics with controlled symptoms had abnormal PFR measurements when PC was between 2 and 21 mg/ml—that is, mild hyperresponsiveness. In contrast, FEV at the time of the histamine test was greater than 80% predicted in all subjects with a PC greater than 2 mg/ml and was not less than this in 10 of 18 subjects with a PC less than 2 mg/ml. When improvement in FEV was 20% or more after salbutamol, the PC was usually moderately or severely increased (less than 0·4 mg/ml). The results identify a close relationship between nonspecific bronchial responsiveness to histamine and the variability in flow rates which occurs spontaneously and after bronchodilator. In addition, they raise the possibility that increased airflow obstruction in asthma may be a consequence of increased responsiveness.
哮喘的特征包括支气管反应性增加和气流速率变异性增加。我们研究了组胺支气管反应性与日间呼气峰值流速(PFR)变化、对沙丁胺醇(200μg)的反应以及组胺试验时的初始第一秒用力呼气容积(FEV)和对沙丁胺醇的FEV反应之间的关系。组胺支气管反应性用引起FEV下降20%的激发浓度(PC)表示。非哮喘受试者的PC范围在13.9至130mg/ml之间,5名无症状哮喘患者的PC范围在10.5至59.9mg/ml之间,27名症状由药物控制的哮喘患者的PC范围在0.03至20.8mg/ml之间。PC越低(支气管反应性越高),早晨PFR越低(r = 0.79),沙丁胺醇后PFR增加越大(早晨r = -0.75,晚上r = -0.80),每天最高和最低PFR之间的差异越大(r = -0.81)。与非哮喘受试者相比,所有PC低于2mg/ml的受试者(即非特异性支气管反应性中度或重度增加)的PFR测量值均异常,而PC高于21mg/ml的受试者(即反应性正常)均无异常;9名症状得到控制的哮喘患者中有5名在PC为2至21mg/ml时(即轻度高反应性)PFR测量值异常。相比之下,组胺试验时的FEV在所有PC大于2mg/ml的受试者中大于预测值的80%,在18名PC小于2mg/ml 的受试者中有10名不低于此值。当沙丁胺醇后FEV改善20%或更多时,PC通常中度或重度增加(小于0.4mg/ml)。结果表明,组胺非特异性支气管反应性与自发和支气管扩张剂后出现的流速变异性之间存在密切关系。此外,它们还提出了哮喘中气流阻塞增加可能是反应性增加的结果这一可能性。